Exagen segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Exagen utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
XGN | Exagen | -$0.28 | -$0.15 | — | — | $12.51M | $17.00M | — | — | 11/11/2025 | |
XGN | Exagen | -$0.16 | -$0.16 | -$0.18 | -12.50% | $15.06M | $16.18M | $17.20M | 6.29% | 07/29/2025 | |
XGN | Exagen | -$0.19 | -$0.21 | -$0.20 | 4.76% | $14.41M | $14.55M | $15.50M | 6.52% | 05/05/2025 | |
XGN | Exagen | -$0.31 | -$0.24 | -$0.20 | 16.67% | $13.77M | $13.85M | $13.65M | -1.41% | 03/11/2025 | |
XGN | Exagen | -$0.31 | -$0.29 | -$0.28 | 3.45% | $13.42M | $13.56M | $12.51M | -7.77% | 11/12/2024 | |
XGN | Exagen | -$0.28 | -$0.35 | -$0.16 | 54.29% | $14.14M | $13.13M | $15.06M | 14.73% | 08/05/2024 | |
XGN | Exagen | -$0.44 | -$0.36 | -$0.19 | 47.22% | $11.23M | $13.09M | $14.41M | 10.12% | 05/13/2024 | |
XGN | Exagen | -$0.83 | -$0.43 | -$0.31 | 27.91% | $12.84M | $11.56M | $13.77M | 19.07% | 03/18/2024 | |
XGN | Exagen | -$0.47 | -$0.46 | -$0.31 | 32.61% | $14.73M | $10.33M | $13.42M | 29.87% | 11/13/2023 | |
XGN | Exagen | -$0.78 | -$0.48 | -$0.28 | 41.67% | $8.96M | $10.97M | $14.14M | 28.90% | 08/07/2023 | |
XGN | Exagen | -$0.60 | -$0.56 | -$0.44 | 21.43% | $10.39M | $9.40M | $11.23M | 19.47% | 05/15/2023 | |
XGN | Exagen | -$0.42 | -$0.78 | -$0.51 | 34.62% | $12.69M | $8.66M | $12.84M | 48.23% | 03/20/2023 | |
XGN | Exagen | -$0.42 | -$0.73 | -$0.47 | 35.62% | $12.25M | $9.13M | $14.73M | 61.29% | 11/14/2022 | |
XGN | Exagen | -$0.38 | -$0.57 | -$0.78 | -36.84% | $12.77M | $12.04M | $8.96M | -25.56% | 08/04/2022 | |
XGN | Exagen | -$0.48 | -$0.61 | -$0.60 | 1.64% | $10.59M | $10.00M | $10.39M | 3.94% | 05/11/2022 | |
XGN | Exagen | -$0.27 | -$0.50 | -$0.42 | 16.00% | $12.67M | $11.80M | $12.69M | 7.53% | 03/22/2022 | |
XGN | Exagen | -$0.34 | -$0.46 | -$0.42 | 8.70% | $10.78M | $12.13M | $12.25M | 1.00% | 11/10/2021 | |
XGN | Exagen | -$0.27 | -$0.44 | -$0.38 | 13.64% | $8.95M | $11.48M | $12.77M | 11.25% | 08/09/2021 | |
XGN | Exagen | -$0.44 | -$0.47 | -$0.48 | -2.13% | $9.58M | $10.45M | $10.59M | 1.31% | 05/11/2021 | |
XGN | Exagen | -$0.27 | -$0.40 | -$0.27 | 32.50% | $10.21M | $10.76M | $12.67M | 17.73% | 03/16/2021 | |
XGN | Exagen | -$2.08 | -$0.48 | -$0.34 | 29.17% | $10.44M | $8.88M | $10.78M | 21.34% | 11/10/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-29 | $-0.18 | $-0.16 | -12.5 % |
Q1 | 2025-05-05 | $-0.20 | $-0.21 | 4.76 % |
Q4 | 2025-03-11 | $-0.20 | $-0.24 | 16.7 % |
Q3 | 2024-11-12 | $-0.28 | $-0.29 | 3.45 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-29 | $17.20M | $16.18M | 6.29 % |
Q1 | 2025-05-05 | $15.50M | $14.55M | 6.52 % |
Q4 | 2025-03-11 | $13.66M | $13.85M | -1.41 % |
Q3 | 2024-11-12 | $12.51M | $13.56M | -7.77 % |
Si prevede che Exagen (XGN) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il luglio 29, 2025 per il Q2.
L'EPS effettivo era $-0.18, che mancato la stima di $-0.16.
Le entrate effettive sono state $17.2M, che superato la stima di $16.2M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.